Ofichem unifies brands under single CDMO and pharmaceutical supplier

Join Pharma | Login

	Editorial


	ACT BEFORE IT IS TOO LATE
	Wednesday, April 8, 2026
	The fierce opposition against the e-pharmacies in the country is getting murkier with lakhs of brick-and-mortar pharmacy stores literally on warpath against the illegal operation of e-pharmacies which adversely affect their livelihood.
	Past Editorial...

TODAY'S NEWS


15:00 [IST]	Ofichem unifies brands under single CDMO and pharmaceutical supplier
14:00 [IST]	Vanda Pharma begins Thetis study, a clinical trial of Nereus for prevention of vomiting induced by GLP-1 receptor agonists
13:00 [IST]	Ecuador Free of Rabies project accelerates progress toward eliminating dog-mediated rabies supported by Boehringer Ingelheim’s Stop Rabies programme
12:00 [IST]	Researchers to examine the long-term effects of sickle cell disease, beta thalassemia, and acute leukaemias by linking health records across England
11:00 [IST]	Interim data from two ongoing investigator-initiated trials highlight the role of Sculptra and Restylane in addressing aesthetic changes associated with weight loss medications and menopause
10:00 [IST]	Novartis announces expansion of community health programmes to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030

more news >>

TOP NEWS


08:00 [IST]	Panel asks DoP to boost domestic manufacturing of all products under PLI scheme for bulk drugs
08:00 [IST]	AIOCD urges DCGI to reconsider ‘cut-strip’ dispensing norms citing safety and financial burden
08:00 [IST]	IPC releases draft NFI-2026 to promote rational use of medicines & to reduce growing burden of AMR
08:00 [IST]	DTAB asks health ministry to scrap draft notification prohibiting ads of Schedule G drugs
08:00 [IST]	AI integration in endoscopy will improve detection of early-stage cancer markers: Expert
08:00 [IST]	DCC approves proposal to create real-time digital portal to track drugs under NDPS Act

more news >>

YESTERDAY'S NEWS


17:40 [IST]	Lupin Foundation inaugurates two NCD Corners in Karauli and Hindaun, Rajasthan
15:45 [IST]	PFRDA unveils NPS Swasthya to integrate retirement savings and healthcare accessibility
15:30 [IST]	Bayer mobilizes 700 doctors nationwide, setting Guinness World Record for women’s nutrition advocacy
15:15 [IST]	Leeford Healthcare revamps Alite product range, plans market expansion
14:15 [IST]	OPPI collaborates with NIPER in Raebareli to advance research excellence
13:45 [IST]	Lupin receives US FDA approval for dapagliflozin and metformin hydrochloride ER tablets

more news >>

INTERVIEW


Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana

Past Interviews...

	What's New?

BSE Healthcare index dips by 4.5% in first quarter of 2026, BSE Sensex drops by 15.5% silver sulfadiazine 1% cream/ointment atleast 200 gm jar tab. lithium carbonate 300mg donepezil 5 mg+ memantine 5 mg tab dasatinib 50 mg tab

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers